Nanomaterials in Personalized Medicine: Global Markets

Nov 2023| HLC144C| BCC Publishing

Report Highlights

The global market for nanomaterials in personalized medicine is expected to increase from $346.7 billion in 2023 to $592.0 billion by the end of 2028, with a compound annual growth rate (CAGR) of 11.3% during the forecast period of 2023-2028.

Report Includes

  • 27 data tables and 50 additional tables
  • An overview of the global market for nanomaterials in personalized medicine
  • Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Discussions of the current and future market potential, and quantification of the market by product type and region
  • Description of emerging technologies such as biomarkers, deep phenotyping, digital precision medicine, genetics, and health information technology; and discussion on ESG trends and pharma end user sustainability in the industry
  • Details about various terms such as monoclonal antibodies (mAbs), nanocrystals, liposomes, their usage in vaccine production, and discussion on how quantum dots work as nanocarriers
  • Insights into advances in nanotechnology by using next-generation vaccines regimes and an overview of the government investments in healthcare sectors
  • Coverage of projects funded by the National Human Genome Research Institute (NHGRI) and other private and government investments, and information on Sanofi in-licensed Exscientia's innovative bispecific small molecule candidate
  • Assessments of innovations and technological advances, the adoption of precision healthcare, and regulatory scenarios, and market drivers, restraints, and opportunities
  • Analysis of the market shares of the key companies and their proprietary technologies, patents, partnerships and alliances and other key strategies
  • Company profiles of major players within the industry, including Bristol-Myers Squibb, Eisai, Gilead Sciences Inc., and Ipsen Pharma

Report Scope

The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.

The scope of the market in this report is segmented into product type and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots. The regional market analysis of nanomaterials in personalized medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India is covered within the regional segments. For market estimates, data is provided for 2022 as the base year, with an estimate for 2023 and forecast value for 2028.

Frequently Asked Questions (FAQs)

The global market for nanomaterials in personalized medicine was valued at $312.8 billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to reach over $592.0 billion by 2028.
The growth of the global market is attributed to factors such as the rising prevalence of chronic diseases globally, rising cancer cases globally, increasing number of diabetes cases worldwide and rising worldwide cases of hypercholesterolemia.
The scope of the market in this report is segmented into product type, and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles and quantum dots.
Therapeutic proteins, or protein drugs, will dominate the market for nanomaterials in personalized medicine. This segment is projected to grow at a CAGR of 12.5% from revenues of $100.7 billion in 2022 to reach $203.2 billion in 2028. By the end of this current decade, most biotechnological products are expected to be the result of protein engineering, which already reflects the current market share.
The North American global market for nanomaterials in personalized medicine was valued at $163.6 billion in 2022 and estimated to be $181.6 billion in 2023. The market is projected to reach $312.0 billion by 2028, growing at a CAGR of 11.4% during the forecast period.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $312.8 billion
Market size forecast $592.0 billion
Growth rate CAGR of 11.3% for the forecast period of 2023-2028
Units considered $ Billions
Segments covered Product Type
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Rest of Asia-Pacific
Key Market Drivers
  • Rising Prevalence of Chronic Diseases Globally
  • Rising Cancer Cases Globally
  • Cancer Mortality
  • Increasing Number of Diabetes Cases Worldwide
  • Rising Worldwide Cases of Hypercholesterolemia
Companies studied
  • BRISTOL-MYERS SQUIBB CO.
  • CAMURUS AB
  • CYTIMMUNE SCIENCES
  • EISAI CO. LTD.
  • GILEAD SCIENCES INC.
  • IPSEN PHARMA

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Nanomaterials in Personalized Medicine: Global Markets226Free
Chapter- 1: Introduction14Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview15Free
Chapter- 4: Nanodevices and Nanomaterials in Diagnostics24Free
Chapter- 5: Treatments Based on Nanomaterial for Infections Associated with Medical Devices8Free
Chapter- 6: Biomedical Nanoparticle Products15Free
Chapter- 7: Therapeutic and Diagnostic Companion Kits3Free
Chapter- 8: Market Dynamics27Free
Chapter- 9: Regulatory Landscape 5Free
Chapter- 10: Impact of COVID-19 on the Market 6Free
Chapter- 11: Market Breakdown by Product Type 40Free
Chapter- 12: Market Breakdown by Region17Free
Chapter- 13: ESG Development7Free
Chapter- 14: Emerging Technologies 3Free
Chapter- 15: Patents and Pipeline Analysis5Free
Chapter- 16: M&A Outlook2Free
Chapter- 17: Competitive Landscape8Free
Chapter- 18: Company Profiles17Free
Chapter- 19: Appendix: Acronyms6Free
Published - Mar-2021| Analyst - BCC Publishing| Code - HLC144B

Report Highlights

The global nanomaterials in personalized medicines market should reach $420.0 billion by 2025 from $253.8 billion in 2020 at a compound annual growth rate (CAGR) of 10.6% for the forecast period of 2020 to 2025.

Report Includes

  • 43 tables
  • A brief outlook of the global market for nanomaterials used in personalized medicine and pharmaceuticals within the industry
  • Analyses of the global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
  • In-depth competitive market analysis of the key industry participants, their company share analysis, global rankings and product offerings
  • Estimation of the actual market size and revenue forecasts for nanomaterials used in personalized medicine, and corresponding market share analysis by product type and region for each key market segment
  • Discussion of market potential for nanomaterial applications in medicine and pharmaceuticals, industry value chain analysis, technology updates, and market growth drivers within the segment
  • Insight into nanomaterial-based treatment methods for infections associated with medical devices and regulatory frameworks for personalized medicine
  • Evaluation of global nanotechnology patents and significant allotment of patent data
  • Company profiles of the leading industry players, including Novartis AG, Bristol-Myers Squibb Co., Beckman coulter, Merck & Co., Inc and Cytimmune Sciences
Published - Jul-2013| Analyst - Alessandro Varotto| Code - HLC144A

Report Highlights

The global theranostic nanomaterial market was estimated to total nearly $106 billion in 2011 and $112 billion in 2012. The market should total nearly $188 billion by 2017, and have a five-year compound annual growth rate (CAGR) of 10.8%.

This report provides:

  • An overview of the global market for nanomaterials in medicine used for both therapy and diagnostics, or theranostics.
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Discussion of the advantages of nanoscale materials, such as in the fabrication of nano-machines that can deliver their cargo (a drug) to a precise location (for instance, the tumor tissue of a specific organ) so that healthy tissues are minimally affected, and in the fabrication of nano-drugs, diagnosis in vivo and therapeutic applications.
  • Examination of the role of theranostics in oncology, immunodeficiencies, and cardiovascular and neuro disorders.
  • Identification of the types of theranostic agents, such as gold-based, magnetic, polymeric, silica-based, carbon, composite, and lyposome nanomaterials.

Nanomaterials in Personalized Medicine: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS